Founding of argenx

At a time where access to human antibody engineering technology was difficult, our co-founders found opportunity where scientific discovery met a new approach to innovation. Hear from Tim Hauwermeiren, CEO, and Hans de Haard, Chief Scientific Officer on how argenx grew from an idea to a global immunology company.